Skip to content

Dual Energy Cone-Beam Computed Tomography (DE-CBCT) Assessment of Jaw Bone Density

A Clinical Trial to Evaluate the Effectiveness and Safety of Dual Energy Cone-Beam Computed Tomography (DE-CBCT) Imaging for Quantitative Measurement of Jaw Bone Density

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04686084
Enrollment
26
Registered
2020-12-28
Start date
2021-03-26
Completion date
2021-11-29
Last updated
2026-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Diseases

Keywords

cone beam computed tomography, dual-energy CT

Brief summary

Current radiologic imaging modalities used in dentistry provide information on the morphology of the hard tissues. Additional information on the density of bone has practical relevance, for example, in dental implant treatment planning, where local bone quality is a known strong predictor of successful implant osseointegration. The Dual-Energy Cone Beam Computed Tomography (DE-CBCT) device is designed to overcome limitations of traditional imaging and will provide assessment of jaw bone density in additional to morphological information. This clinical trial will examine the application of DE-CBCT to assess jaw bone density and compare Hounsfield units (HU) values with multidetector CT, an established standard for assessing BD.

Detailed description

This is a single center, open-label trial, designed to enroll 24 patients. Both, the researcher and the subject know the treatment the participant is receiving. To evaluate the effectiveness and safety of DE-CBCT to evaluate jaw bone density and compare HU values with those of multidetector CT, an established standard for assessing BD. The study is based on two visits (VISIT 1 and VISIT 2) • DAY 0 (enrollment): Subject is queried for inclusion/exclusion criteria and informed about the study. If he/she agrees to participate, inclusion/exclusion criteria and informed consent will be documented. An imaging stent, which bears radiopaque markers, will be also created for each patient. • VISIT 1: Inclusion/exclusion criteria will be reconfirmed and the DE-CBCT imaging will be completed. • VISIT 2 (no more than 30 days since the enrollment): Inclusion/exclusion criteria will be reconfirmed and MDCT imaging completed. \- Depending on availability of scheduling on MDCT unit, Visit 2 may occur on the same day as Visit 1.

Interventions

DEVICEDual-energy computed tomography scan

Diagnostic CT scan

Sponsors

University of California, Los Angeles
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients who need x-ray imaging for dental treatment planning and/or diagnosis 2. Males or females aged older than 21 3. Can follow instructions to be positioned into the CT scanner 4. Can remain physically immobile during the CT scan acquisition 5. Voluntarily sign and date the informed consent

Exclusion criteria

1. Pregnancy 2. Patients who are unable to comprehend the risks of the study to provide informed consent 3. Extensive dental restorations, maxillofacial prosthesis, or orthopedic hardware that likely may cause artifacts and degrade quality, as determined by the study radiologists

Design outcomes

Primary

MeasureTime frameDescription
Bone Density Assessment30 daysBone density (g/cc) in a region of interest measured by the OnDemand software

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORSanjay M Mallya, BDS,MDS,PhD

University of California, Los Angeles

Participant flow

Participants by arm

ArmCount
CT Scan
CT scan (MDCT, standard of care) and DE-CBCT (Investigational) Dual-energy computed tomography scan: Diagnostic CT scan
25
Total25

Baseline characteristics

CharacteristicCT Scan
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
8 Participants
Age, Categorical
Between 18 and 65 years
17 Participants
Sex: Female, Male
Female
12 Participants
Sex: Female, Male
Male
13 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 25
other
Total, other adverse events
0 / 25
serious
Total, serious adverse events
0 / 25

Outcome results

Primary

Bone Density Assessment

Bone density (g/cc) in a region of interest measured by the OnDemand software

Time frame: 30 days

Population: Patients imaged with MDCT and DE-CBCT

ArmMeasureValue (MEAN)Dispersion
CT ScanBone Density Assessment0.48 g/ccStandard Deviation 0.31
DE-CBCT Scan (Investigational)Bone Density Assessment0.46 g/ccStandard Deviation 0.36

Source: ClinicalTrials.gov · Data processed: Jun 5, 2026